The discussion between professionals of how to rebuild public trust regarding clinical trials may stem from the worldwide concern in the biomedical research community about the low capture rate of trials reported as reported on redOrbit.com. One theory to help raise clinical trial support is a clear informed consent form. Both Mark A. Yarborough, PhD., and Daniel I. Sessler, MD., believe in this theory but in different ways. Using the same principle, Dr. Yarborough sides with more transparency, while Dr. Sessler describes consent to be asked at different times. Another theory, from Barbara A. Koenig, PhD., realizes the importance of informed consent, but finds that more, well designed trials would create a more positive push to the public. All three experts have quality reasoning behind each of their ideas. Where do you weigh in on the subject? What will shine a positive light on clinical trials to the public? Read the full article here.
Single IRB – A Guide to the Common Rule sIRB Mandate
The sIRB requirement is active. Is your study affected?
Clinical Research Accelerated
You need high quality, timely board reviews so that you can get your study in the clinic.
Recent Posts
Pearl IRB 2024 Year-End Schedule
Snowball Sampling: Is it ethical to pay your study subjects to recruit participants on your behalf?
Improving Exempt Submissions: 7 Tips to Reduce Revision Requests
Common Rule Exceptions to the Use of a Single IRB for Multi-site Research Ends After May 11, 2023
Pearl IRB 2022 Year-End Schedule